| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 |
| Total Revenue | 3,321 |
-
| 850 |
| Cost of Revenue | 2,321 |
-
| 413 |
|
| Gross Profit | 999 |
-
| 437 |
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
| Selling General and Administrative | 1,804 | 990 | 1,118 |
| Non Recurring |
-
|
-
|
-
|
| Others |
-
|
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
|
|
| Operating Income or Loss | (805) | (990) | (681) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | (89) | 331 | 369 |
| Earnings Before Interest And Taxes | (894) | (659) | (311) |
| Interest Expense | 2 |
-
|
-
|
| Income Before Tax | (896) | (659) | (311) |
| Income Tax Expense |
-
|
-
|
-
|
| Minority Interest |
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | (896) | (659) | (311) |
|
| Non-recurring Events |
| Discontinued Operations | 89 | (13) |
-
|
| Extraordinary Items |
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
|
|
| Net Income | (807) | (672) | (311) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | ($807) | ($672) | ($311) |
0.29% Nasdaq 
Income Statement
